Cargando…

New insights into pathogenesis point to HIV-1 Tat as a key vaccine target

Despite over 30 years of enormous effort and progress in the field, no preventative and/or therapeutic vaccines against human immunodeficiency virus (HIV) are available. Here, we briefly summarize the vaccine strategies and vaccine candidates that in recent years advanced to efficacy trials with mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ensoli, Barbara, Moretti, Sonia, Borsetti, Alessandra, Maggiorella, Maria Teresa, Buttò, Stefano, Picconi, Orietta, Tripiciano, Antonella, Sgadari, Cecilia, Monini, Paolo, Cafaro, Aurelio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363864/ https://www.ncbi.nlm.nih.gov/pubmed/34390393 http://dx.doi.org/10.1007/s00705-021-05158-z

Ejemplares similares

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease
por: Cafaro, Aurelio, et al.
Publicado: (2019)

HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication
por: Cafaro, Aurelio, et al.
Publicado: (2020)

Kaposi’s Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies
por: Brocca-Cofano, Egidio, et al.
Publicado: (2022)

Anti-Tat immunity defines CD4(+) T-cell dynamics in people living with HIV on long-term cART.
por: Tripiciano, Antonella, et al.
Publicado: (2021)

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
por: Sgadari, Cecilia, et al.
Publicado: (2019)

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
por: Ensoli, Barbara, et al.
Publicado: (2016)

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
por: Ensoli, Fabrizio, et al.
Publicado: (2015)

HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
por: Monini, Paolo, et al.
Publicado: (2012)

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4(+) T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study
por: Bellino, Stefania, et al.
Publicado: (2014)

Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines
por: Titti, Fausto, et al.
Publicado: (2014)

Effect of MHC Haplotype on Immune Response upon Experimental SHIV(SF162P4cy) Infection of Mauritian Cynomolgus Macaques
por: Borsetti, Alessandra, et al.
Publicado: (2014)

Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
por: Sgadari, Cecilia, et al.
Publicado: (2011)

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS
por: Moretti, Sonia, et al.
Publicado: (2021)

The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies
por: Barillari, Giovanni, et al.
Publicado: (2018)

Challenges in HIV Vaccine Research for Treatment and Prevention
por: Ensoli, Barbara, et al.
Publicado: (2014)

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
por: Ensoli, Barbara, et al.
Publicado: (2010)

The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation
por: Nicoli, Francesco, et al.
Publicado: (2020)

Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy
por: Farcomeni, Stefania, et al.
Publicado: (2021)

The HIV-1 Tat Protein Induces the Activation of CD8(+) T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses
por: Nicoli, Francesco, et al.
Publicado: (2013)

HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology
por: Cafaro, Aurelio, et al.
Publicado: (2016)

HIV-1–Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities
por: Moretti, Sonia, et al.
Publicado: (2023)

Molecular Characterization of HIV-1 Subtype C gp-120 Regions Potentially Involved in Virus Adaptive Mechanisms
por: Cenci, Alessandra, et al.
Publicado: (2014)

Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort
por: Nicoli, Francesco, et al.
Publicado: (2016)

An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge
por: Sicurella, Mariaconcetta, et al.
Publicado: (2014)

Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017–2019 multicenter cross-sectional study
por: Maggiorella, Maria Teresa, et al.
Publicado: (2023)

Induction of Antibodies and T Cell Responses by a Recombinant Influenza Virus Carrying an HIV-1 TatΔ(51–59) Protein in Mice
por: Garulli, B., et al.
Publicado: (2014)

High HIV-1 diversity in immigrants resident in Italy (2008–2017)
por: Maggiorella, Maria Teresa, et al.
Publicado: (2020)

Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma
por: Ceccarelli, Giancarlo, et al.
Publicado: (2022)

HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation
por: Remoli, Anna Lisa, et al.
Publicado: (2016)

Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells
por: Bacigalupo, Ilaria, et al.
Publicado: (2017)

TatBC-Independent TatA/Tat Substrate Interactions Contribute to Transport Efficiency
por: Taubert, Johannes, et al.
Publicado: (2015)

How to achieve Tat transport with alien TatA
por: Hauer, René Steffen, et al.
Publicado: (2017)

Substrate-triggered position switching of TatA and TatB during Tat transport in Escherichia coli
por: Habersetzer, Johann, et al.
Publicado: (2017)

Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses
por: Bose, Deepanwita, et al.
Publicado: (2015)

Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels
por: Barillari, Giovanni, et al.
Publicado: (2016)

Khosta: A Genetic and Structural Point of View of the Forgotten Virus
por: Scarpa, Fabio, et al.
Publicado: (2023)

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
por: Mediouni, Sonia, et al.
Publicado: (2015)

TatA and TatB generate a hydrophobic mismatch important for the function and assembly of the Tat translocon in Escherichia coli
por: Mehner-Breitfeld, Denise, et al.
Publicado: (2022)

Characterization of a TatA/TatB binding site on the TatC component of the Escherichia coli twin arginine translocase
por: Severi, Emmanuele, et al.
Publicado: (2023)

HIV-1 Tat alters neuronal intrinsic excitability
por: Francesconi, Walter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jv40ptnm9s2ddnvl6mmatm5601